International Journal of Women's Health · Nov 10, 2026

Burden and Temporal Trends of Female Breast Cancer Attributable to High Fasting Plasma Glucose in China and G20 Countries, 1990-2023: An Analysis of the Global Burden of Disease Study 2023

By Zheng J, Ye Z, Chen S et al.

OBJECTIVE: This study aimed to characterise the burden, temporal trends and geographical variation of female breast cancer attributable to high fasting plasma glucose (HFPG) in China and G20 countries from 1990 to 2023, and to provide evidence for targeted prevention and control strategies. METHODS: Attributable burden estimates from the Global Burden of Disease Study 2023 (GBD 2023) were used to compare HFPG-attributable female breast cancer mortality and disability-adjusted life-years (DALYs) between China and G20 countries from 1990 to 2023. Joinpoint regression and age-period-cohort (APC) analyses assessed temporal trends in this burden. Spearman's correlation analysis explored its association with the Socio-demographic index (SDI) gradient, and decomposition analysis quantified the separate contributions of population ageing, population growth, and epidemiological transitions to changes in burden. A Bayesian age-period-cohort (BAPC) model was applied to project these burden estimates for 2024-2038. RESULTS: From 1990 to 2023, HFPG-attributable breast cancer deaths, as estimated by the GBD comparative risk assessment framework, increased by 111.19% (15,672 additional deaths) across G20 countries, while age-standardised mortality rate (ASMR) and age-standardised DALY rate (ASDR) modestly decreased by 8.33% and 7.54%. In China, attributable deaths rose by 55.18% (1842 additional deaths), with ASMR and ASDR falling sharply by 38.89% and 43.75%. Marked heterogeneity was observed across G20 countries. Both ASMR and ASDR showed a rebound between 2020 and 2023 in China and G20 countries. The SDI exhibited an inverted U-shaped association with ASMR and ASDR. Population growth and ageing were key contributors to rising attributable burden. BAPC projections suggest that the absolute burden will continue to increase over the subsequent 15 years. CONCLUSION: Over the past 30 years, the absolute burden of female breast cancer attributed to HFPG in China and G20 countries has shown an upward trend. Based on BAPC projections, this burden may continue to increase over the next 15 years. Given the significant differences in the characteristics of the transnational burden, countries should adopt targeted public health interventions tailored to their national conditions, such as population size, social development level, and healthcare environment, to address this potential trend.

doi.org/10.2147/ijwh.s648762Open accessPubMed 43034638Populations

AgingResearch.News